Skip to main content
Be The Investor
Home›Stocks›A
A

Agilent Technologies, Inc.

A
NYSEUnited States flagUSReal-Time Price
$173.11USD
+3.21 (+1.89%)Today
$174.00+0.89 (+0.51%)Pre-Market5:35 PM ET
BTI Score
Near Future
64
Long Term
68
BTI Fair Market Cap
$27.77B
+75.74% vs fair
Healthcare & Pharma
Hold

Agilent Technologies, Inc. (A) Stock Overview

Agilent Technologies, Inc. (A) is a Healthcare company in the Medical - Diagnostics & Research industry listed on NYSE. Review available quotes, BTI valuation, financial statements, earnings, news and risk information.

Market Cap
$48.80B
Enterprise Value
$51.00B
Volume
1.98M
Avg. Volume
2.27M
P/E (TTM)
33.45
Forward P/E
24.96
EPS (TTM)
$5.09
Profit Margin
19.53%
FCF Margin
+19.48%
Dividend Yield
0.75%
Beta
1.21
52 Week Range
$108.35$177.47
Next Earnings
2026-11-23
Time TBD
Investor Snapshot
Analyst Consensus
Strong Buy
Based on 29 analysts
🟢 Buy 21
🟡 Hold 8
🔴 Sell 2
Average Price Target
$181.05
+4.59% Upside
High $196.00Low $155.00
Expected Upside
+4.59%
From current price
Valuation Status
Fair Value
Justified
UndervaluedOvervalued
Risk Level
Moderate

A Price Chart

Trend:
Momentum:
Volatility:
Volume:

Analyst Insights

Strong Buy
Based on 29 analysts
Buy21
Hold8
Sell2

Earnings Trends

Earnings Per Share

↗

Revenue Beat Rate

82%
Beat Rate
Beat9
Meet0
Miss2
Total11
↗

EPS Beat Rate

50%
Beat Rate
Beat2
Meet0
Miss2
Total4
★

Analyst Expectations

68%
Positive
Above21
In-Line8
Below2
Total31

Quarterly EPS Performance

Recent results and upcoming quarter
Q1 FY26
31 / 03 / 2026
Upcoming
Estimate—Actual—Surprise—
Q2 FY26
30 / 06 / 2026
Beat
Estimate$1.44Actual$1.49Surprise+$0.05 (+3.83%)
Q3 FY26
30 / 09 / 2026
Beat
Estimate$1.52Actual$1.62Surprise+$0.10 (+6.90%)
Q4 FY26
23 / 11 / 2026
Upcoming
Estimate$1.72Actual—Surprise—

Quarterly Revenue Performance

Actual quarterly revenue with consensus when available
Q1 FY26
31 / 01 / 2026
miss
Estimate$1.81BActual$1.80BSurprise$-10.01M (-0.55%)
Q2 FY26
30 / 04 / 2026
beat
Estimate$1.80BActual$1.83BSurprise$36.50M (+2.03%)
Q3 FY26
31 / 07 / 2026
beat
Estimate$1.84BActual$1.88BSurprise$36.49M (+1.98%)
Q4 FY26
23 / 11 / 2026
upcoming
Estimate$1.99BActual—Surprise—

Revenue vs Earnings Over Time

Revenue (B USD)Net Income (B USD)Profit Margin (%)
FY22FY23FY24FY25FY26024680%5%10%15%20%18.3%18.1%19.8%18.8%19.5%
Source: Yahoo Finance quarterly financialsYoY comparison
A upcoming earnings call
2026-11-23 at 4:30 PM EST
Coming SoonTime TBD

Earnings Call Hub

Listen live or replay earnings calls with AI-powered insights.

Coming SoonTime TBD
A upcoming earnings call
2026-11-23
Reminder via

AI Call Summary

Beta

A is expected to report results shaped by demand trends, margin performance and management guidance. Investors should watch earnings quality, cash flow and outlook commentary.

Call Agenda

Revenue Review
Guidance & Outlook
Data Center Update
HBM Growth
NAND Market
Q&A Session

Recent News

Company Overview

A
CEO
Padraig McDonnell
Founded
1999
Employees
18,200
Headquarters
Santa Clara, CA
Industry
Medical - Diagnostics & Research